[On the therapy of liver diseases with ornithine aspartate].
D000208:Acute Disease; D000410:Alanine Transaminase / Q000097:blood; D000641:Ammonia / Q000097:blood; D001224:Aspartic Acid / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D002761:Cholangitis / Q000188:drug therapy; D002908:Chronic Disease; D004361:Drug Tolerance; D005234:Fatty Liver / Q000188:drug therapy; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007501:Iron / Q000097:blood; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000097:blood / Q000188:drug therapy*; D008111:Liver Function Tests; D009952:Ornithine / Q000627:therapeutic use*; D013448:Sulfobromophthalein
D013448:Sulfobromophthalein; D001224:Aspartic Acid; D000641:Ammonia; D007501:Iron; D009952:Ornithine; D000410:Alanine Transaminase; D001663:Bilirubin
Zur Therapie von Leberkrankheiten mit Ornithinaspartat.